Financial Counselors Inc Takeda Pharmaceutical CO LTD Transaction History

Financial Counselors Inc

  • $6.67 Billion
  • Q3 2024

A detailed history of Financial Counselors Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Financial Counselors Inc holds 24,817 shares of TAK stock, worth $336,766. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,817
Previous 25,122 1.21%
Holding current value
$336,766
Previous $325,000 8.31%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$13.0 - $15.08 $3,965 - $4,599
-305 Reduced 1.21%
24,817 $352,000
Q2 2024

Aug 01, 2024
SELL
$12.6 - $13.67 $3,187 - $3,458
-253 Reduced 1.0%
25,122 $325,000
Q1 2024

May 02, 2024
SELL
$13.89 - $15.04 $2,194 - $2,376
-158 Reduced 0.62%
25,375 $352,000
Q4 2023

Jan 26, 2024
SELL
$13.36 - $15.43 $1,683 - $1,944
-126 Reduced 0.49%
25,533 $364,000
Q3 2023

Nov 07, 2023
SELL
$15.03 - $16.32 $601 - $652
-40 Reduced 0.16%
25,659 $396,000
Q2 2023

Jul 27, 2023
SELL
$15.57 - $17.11 $887 - $975
-57 Reduced 0.22%
25,699 $404,000
Q1 2023

May 02, 2023
SELL
$15.28 - $16.48 $2,918 - $3,147
-191 Reduced 0.74%
25,756 $424,000
Q4 2022

Feb 14, 2023
SELL
$12.42 - $15.62 $1,055 - $1,327
-85 Reduced 0.33%
25,947 $405,000
Q3 2022

Nov 01, 2022
SELL
$12.8 - $28.65 $1,497 - $3,352
-117 Reduced 0.45%
26,032 $338,000
Q2 2022

Aug 02, 2022
SELL
$13.12 - $15.03 $22,133 - $25,355
-1,687 Reduced 6.06%
26,149 $367,000
Q1 2022

Apr 28, 2022
SELL
$13.54 - $15.35 $7,338 - $8,319
-542 Reduced 1.91%
27,836 $399,000
Q4 2021

Feb 10, 2022
SELL
$13.17 - $16.4 $5,347 - $6,658
-406 Reduced 1.41%
28,378 $387,000
Q3 2021

Oct 26, 2021
SELL
$16.3 - $17.26 $1,075 - $1,139
-66 Reduced 0.23%
28,784 $471,000
Q2 2021

Aug 03, 2021
SELL
$16.55 - $18.64 $8,142 - $9,170
-492 Reduced 1.68%
28,850 $486,000
Q1 2021

Apr 29, 2021
SELL
$16.71 - $19.9 $1,470 - $1,751
-88 Reduced 0.3%
29,342 $536,000
Q4 2020

Feb 10, 2021
SELL
$15.39 - $18.97 $1,615 - $1,991
-105 Reduced 0.36%
29,430 $536,000
Q3 2020

Nov 16, 2020
SELL
$17.1 - $19.19 $4,531 - $5,085
-265 Reduced 0.89%
29,535 $527,000
Q2 2020

Aug 07, 2020
SELL
$14.59 - $19.5 $919 - $1,228
-63 Reduced 0.21%
29,800 $534,000
Q1 2020

Apr 23, 2020
SELL
$13.02 - $20.31 $3,593 - $5,605
-276 Reduced 0.92%
29,863 $453,000
Q4 2019

Jan 31, 2020
SELL
$16.88 - $20.83 $3,139 - $3,874
-186 Reduced 0.61%
30,139 $595,000
Q3 2019

Nov 08, 2019
SELL
$16.15 - $17.99 $888 - $989
-55 Reduced 0.18%
30,325 $522,000
Q2 2019

Aug 14, 2019
SELL
$16.58 - $20.49 $5,487 - $6,782
-331 Reduced 1.08%
30,380 $538,000
Q1 2019

May 10, 2019
BUY
$16.7 - $21.52 $512,873 - $660,900
30,711 New
30,711 $626,000

Others Institutions Holding TAK

# of Institutions
337
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email